Target RWE Acquires Curation Team from Ciox Health
August 24, 2022
Durham-based real-world evidence company Target RWE acquired the legacy Real World Data curation team from Ciox Health, adding roughly 35 full-time and part-time employees and expanding its data abstraction and curation capabilities. The acquisition strengthens Target RWE's RWD solutions and complements its prior analytics purchase (NoviSci) as the company scales its RWE offerings.
- Buyers
- Target RWE
- Targets
- Ciox Health (legacy Real World Data curation team)
- Sellers
- Ciox Health
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Datavant to Acquire Aetion, Creating an End-to-End Real-World Evidence Platform
July 13, 2025
Healthcare Services
Datavant signed an agreement to acquire Aetion, a real-world evidence (RWE) platform used for healthcare and life sciences decision-making. The combined offering is intended to provide end-to-end RWE capabilities spanning data discovery, linkage, privacy, curation, and advanced analysis for regulators and industry stakeholders.
-
Reveleer Acquires Curation Health
October 8, 2024
Healthcare Services
Reveleer, a value-based care enablement platform backed by Oak HC/FT, has acquired Curation Health to expand its clinical intelligence and EHR integration capabilities. The acquisition brings Curation Health's proprietary clinical rules and deep EMR integrations (EPIC, Cerner, Athena) into Reveleer's platform to enhance point-of-care insights, risk adjustment, and quality improvement.
-
Thermo Fisher Scientific Acquires CorEvitas from Audax Private Equity
July 6, 2023
Data & Analytics
Thermo Fisher Scientific agreed to acquire CorEvitas, a Waltham, Massachusetts–based real-world evidence (RWE) and clinical registries provider, from Audax Private Equity for $912.5 million in cash. The acquisition, completed August 14, 2023, will fold CorEvitas (approximately 300 employees; expected 2023 revenue ~$110M) into Thermo Fisher’s Laboratory Products and Biopharma Services segment to expand its RWE and life‑sciences data capabilities.
-
Alira Health Acquires Self Care Catalysts
January 25, 2022
Healthcare Services
Alira Health has acquired Toronto-based Self Care Catalysts, the developer of the Health Storylines patient-centric digital health platform. The deal adds patient engagement, decentralized clinical trial (DCT) and real-world evidence (RWE) capabilities to Alira's global portfolio and strengthens its presence in North America.
-
Target RWE Acquires NoviSci Inc.
January 15, 2021
Healthcare Services
Target RWE, a Durham-based real-world evidence solutions company, has acquired NoviSci, Inc., a software analytics and services firm that applies epidemiologic methods and causal inference to health data. Amgen Inc. also made a strategic investment in the combined company, joining existing investors Norwest Venture Partners and 22C Capital to support growth; financial terms were not disclosed.
-
IMS Health Acquires Privacy Analytics
May 25, 2016
Data & Analytics
IMS Health acquired Privacy Analytics to integrate its de-identification and data governance technology into IMS Health’s Real-World Evidence (RWE) platform, expanding the company’s capabilities in privacy-preserving analytics for life sciences and healthcare clients. The acquisition will allow IMS Health to offer Privacy Analytics’ software and advisory services across its global client base while continuing to offer the solutions as an independent product suite.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.